Novadip Biosciences SA - Company Review
Novadip Biosciences SA - Company ReviewSummary
Novadip Biosciences SA (Novadip) is a healthcare products provider that offers cell-based regeneration therapies. The company’s pipeline product include NVD-001, a patented cellular therapy to treat bone healing disorders and defects, and NVD-002, a therapy for dermal reconstruction. Its product uses autologous adipose-derived mesenchymal stem cells that offers wide range of benefits, which include minimally invasive isolation procedure, a high capacity of differentiation, and reduced risk of recipient immunisation or graft rejection. Novadip develops therapies to treat patients with bone defects and bone diseases. Its products are also applied in other indications such as orthopaedic surgery for trauma or tumour resection, neurosurgery for spine, cranial and maxillofacial surgery, and osteonecrosis, among others. Novadip is headquartered in Mont-Saint-Guibert, Belgium.
This comprehensive company report of Novadip Biosciences SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.